The findings were reached using an analytic hierarchy process, which can help physicians review options with patients who have never experienced either exam.
"Diversity is vital to healthcare, and this court ruling deals a serious blow to our goal of increasing medical career opportunities for historically marginalized and minoritized people."
The consortium of cancer care stakeholders recently held a launch event, with others involved including the ACR, Johnson & Johnson, and drug company AstraZeneca.